Abiraterone for Metastatic Prostate Cancer With Suboptimal Response to Hormone Induction

This study evaluated the use of abiraterone acetate plus prednisone in men with metastatic prostate cancer.

from Cancer via ola Kala on Inoreader http://ift.tt/2zueBez
via IFTTT